Top Deals
Mar. 12, 2015
Attorneys reflect on Valeant-Allergan buyout saga
One of the most contentious, unique and closely watched deals of 2014 was one that never actually took place.
Daily Journal Staff Writer
One of the most contentious, unique and closely watched deals of 2014 was one that never actually took place.
For nearly six months, Quebec-based Valeant Pharmaceutical International Inc., working in concert with the hedge fund Pershing Square Capital Management LP, pursued Allergan Inc. in Irvine with a dogged tenacity that rivaled any attempted hostile takeover in recent memory.
...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In